These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 2943876)

  • 1. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.
    Shepard KV; Levin B; Karl RC; Faintuch J; DuBrow RA; Hagle M; Cooper RM; Beschorner J; Stablein D
    J Clin Oncol; 1985 Feb; 3(2):161-9. PubMed ID: 3155793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
    Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional chemotherapy of colorectal cancer metastatic to the liver.
    Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E
    Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
    J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival.
    Patt YZ; Charnsangavej C; Yoffe B; Smith R; Lawrence D; Chuang V; Carrasco H; Roh M; Chase J; Fischer H
    J Clin Oncol; 1994 Jun; 12(6):1204-11. PubMed ID: 8201383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
    Cohen AM; Schaeffer N; Higgins J
    Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy.
    Cohen AM; Kaufman SD; Wood WC
    Dis Colon Rectum; 1985 Jun; 28(6):389-93. PubMed ID: 3159555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
    Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A
    J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
    Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR; Garnick MB; Osteen RT; Steele GD; Wilson RE; Schade D; Kaplan WD; Boxt LM; Kandarpa K; Mayer RJ
    J Clin Oncol; 1983 May; 1(5):337-44. PubMed ID: 6199474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
    Sigurdson ER; Ridge JA; Daly JM
    Surgery; 1986 Aug; 100(2):285-91. PubMed ID: 2943036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of postoperative hepatic arterial infusion following curative liver resection.
    Lorenz M; Staib-Sebler E; Koch B; Gog C; Waldeyer M; Encke A
    Anticancer Res; 1997; 17(5B):3825-33. PubMed ID: 9427788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.